Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing
Authors
Keywords
COVID 19, Diabetes mellitus, SARS CoV 2, Death rates, Blood sugar, Respiratory infections, Inflammation, SARS
Journal
PLoS Pathogens
Volume 17, Issue 6, Pages e1009634
Publisher
Public Library of Science (PLoS)
Online
2021-06-23
DOI
10.1371/journal.ppat.1009634
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19
- (2021) Yun Kit Yeoh et al. GUT
- The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus
- (2021) Mao Zheng et al. Journal of Diabetes Research
- Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes
- (2021) Andrew B. Crouse et al. Frontiers in Endocrinology
- Flavonoids against the SARS-CoV-2 induced inflammatory storm
- (2021) Alena Liskova et al. BIOMEDICINE & PHARMACOTHERAPY
- Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Metformin-induced suppression of IFN-α via mTORC1 signalling following seasonal vaccination is associated with impaired antibody responses in type 2 diabetes
- (2020) Wipawee Saenwongsa et al. Scientific Reports
- Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19
- (2020) Javier A. Menendez Aging-US
- Coronaviruses fusion with the membrane and entry to the host cell
- (2020) Ewelina Wędrowska et al. ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Lihua Zhu et al. Cell Metabolism
- Comment on “Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?”
- (2020) Erkan Cure et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- COVID-19 and diabetes: Is metformin a friend or foe?
- (2020) Francesco Ursini et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
- (2020) Wei-jie Guan et al. EUROPEAN RESPIRATORY JOURNAL
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- Summary of recommendations regarding COVID ‐19 in children with diabetes: Keep Calm and Mind your Diabetes Care and Public Health Advice
- (2020) PEDIATRIC DIABETES
- Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
- (2020) Barry Rockx et al. SCIENCE
- Clinical characteristics and outcomes of patients with severe covid-19 with diabetes
- (2020) Yongli Yan et al. BMJ Open Diabetes Research & Care
- The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms
- (2020) Lo’ai Alanagreh et al. Pathogens
- Coronavirus membrane fusion mechanism offers a potential target for antiviral development
- (2020) Tiffany Tang et al. ANTIVIRAL RESEARCH
- Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis
- (2020) Ana Campos Codo et al. Cell Metabolism
- A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids
- (2020) Liuliu Yang et al. Cell Stem Cell
- Managing Hyperglycemia in the COVID-19 Inflammatory Storm
- (2020) Roma Gianchandani et al. DIABETES
- Metformin and COVID-19: From cellular mechanisms to reduced mortality
- (2020) A.J. Scheen DIABETES & METABOLISM
- Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review
- (2020) Awadhesh Kumar Singh et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
- (2020) Awadhesh Kumar Singh et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A proposed mechanism for the possible therapeutic potential of Metformin in COVID-19
- (2020) Zohreh Esam DIABETES RESEARCH AND CLINICAL PRACTICE
- Metformin in COVID-19: A possible role beyond diabetes
- (2020) Swati Sharma et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study
- (2020) Sufei Wang et al. DIABETOLOGIA
- Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
- (2020) Alice Huertas et al. EUROPEAN RESPIRATORY JOURNAL
- Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome
- (2020) Loris Roncon et al. JOURNAL OF CLINICAL VIROLOGY
- COVID-19 in people with diabetes: understanding the reasons for worse outcomes
- (2020) Matteo Apicella et al. Lancet Diabetes & Endocrinology
- Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
- (2020) Naomi Holman et al. Lancet Diabetes & Endocrinology
- Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study
- (2020) Emma Barron et al. Lancet Diabetes & Endocrinology
- Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
- (2020) George Goshua et al. Lancet Haematology
- COVID-19 and Diabetes: The Importance of Controlling RAGE
- (2020) Ernestina M. De Francesco et al. Frontiers in Endocrinology
- COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
- (2020) Razie Amraei et al. Cells
- ACE2, Metformin, and COVID-19
- (2020) Atul Malhotra et al. iScience
- Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Xu Cheng et al. Cell Metabolism
- Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses
- (2020) Eleni Gavriilaki et al. CURRENT HYPERTENSION REPORTS
- New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K.
- (2020) Rebecca Unsworth et al. DIABETES CARE
- Metformin is associated with Decreased 30-day Mortality among Nursing Home Residents Infected with SARS-CoV2
- (2020) Michelle Lally et al. Journal of the American Medical Directors Association
- Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications
- (2020) Nehla Banu et al. LIFE SCIENCES
- Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral–bacterial interactions
- (2020) Ilja L Kruglikov et al. eLife
- COVID-19 Usurps Host Regulatory Networks
- (2020) Colleen S. Curran et al. Frontiers in Pharmacology
- Diabetes, infection risk and COVID-19
- (2020) Suheda Erener Molecular Metabolism
- Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19
- (2020) Jean-Daniel Lalau et al. DIABETES & METABOLISM
- COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes
- (2020) Justin M. Gregory et al. DIABETES CARE
- Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: a retrospective cohort study
- (2020) Nan Jiang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis
- (2019) Yechen Han et al. Cardiovascular Diabetology
- Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer
- (2019) Tala M. Abu Samaan et al. Biomolecules
- Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
- (2019) Samson Mathews Samuel et al. Biomolecules
- AMPK Phosphorylation of ACE2 in Endothelium Mitigates Pulmonary Hypertension
- (2018) Jiao Zhang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Targeting RAGE Signaling in Inflammatory Disease
- (2018) Barry I. Hudson et al. Annual Review of Medicine
- Metformin, A New Era for an Old Drug in the Treatment of Immune Mediated Disease?
- (2018) Mark Schuiveling et al. CURRENT DRUG TARGETS
- The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)
- (2018) Robson Augusto Souza Santos et al. PHYSIOLOGICAL REVIEWS
- Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
- (2018) Christoph A. Thaiss et al. SCIENCE
- Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells
- (2018) Jean Kaoru Millet et al. VIROLOGY
- Insulin Receptor-Mediated Stimulation Boosts T Cell Immunity during Inflammation and Infection
- (2018) Sue Tsai et al. Cell Metabolism
- Metformin Targets Mitochondrial Electron Transport to Reduce Air-Pollution-Induced Thrombosis
- (2018) Saul Soberanes et al. Cell Metabolism
- Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
- (2017) Hao Wu et al. NATURE MEDICINE
- Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium
- (2016) C. R. Triggle et al. Acta Physiologica
- Anti-Inflammatory Effects of Metformin Irrespective of Diabetes StatusNovelty and Significance
- (2016) Amy R. Cameron et al. CIRCULATION RESEARCH
- NHX-5, an Endosomal Na+/H+Exchanger, Is Associated with Metformin Action
- (2016) Jeongho Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Emerging pathogenic links between microbiota and the gut–lung axis
- (2016) Kurtis F. Budden et al. NATURE REVIEWS MICROBIOLOGY
- Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression
- (2016) Zhong’e Zhou et al. Journal of Diabetes Research
- Metformin Uniquely Prevents Thrombosis by Inhibiting Platelet Activation and mtDNA Release
- (2016) Guang Xin et al. Scientific Reports
- ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice
- (2015) Robin Shoemaker et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Loss of ACE2 Exaggerates High-Calorie Diet–Induced Insulin Resistance by Reduction of GLUT4 in Mice
- (2012) Masao Takeda et al. DIABETES
- Diabetes and the Severity of Pandemic Influenza A (H1N1) Infection
- (2010) R. Allard et al. DIABETES CARE
- SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway
- (2008) Hongliang Wang et al. CELL RESEARCH
- Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet-Induced Obesity and Diabetes in Mice
- (2008) P. D. Cani et al. DIABETES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started